BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 18, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Self-amplifying mRNA technology underscored for next big pandemic
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Alteon initiates phase III trials of pimagedine
Aug. 23, 1996
Johnson & Johnson continues pramlintide collaboration
Aug. 23, 1996
Pramlintide shows positive safety/efficacy profile in phase II
Aug. 23, 1996
Humalog launched on U.S. market
Aug. 23, 1996
Hematopoiesis-stimulating compounds from Nycomed Pharma
Aug. 23, 1996
RIIbeta: Potential antiobesity drug target
Aug. 23, 1996
CCK-A agonist from Glaxo Wellcome
Aug. 23, 1996
New hypolipidemic agent from Schering-Plough
Aug. 23, 1996
Metachol distribution agreement
Aug. 23, 1996
Eisai's squalene synthase inhibitor and prodrug
Aug. 23, 1996
Previous
1
2
…
1742
1743
1744
1745
1746
1747
1748
1749
1750
…
1769
1770
Next
RSS